Search research articles
Contact Us
Filters
Showing results (161-170 of 181) with videos related to
Page
of 19
Sort By:
BMC Cancer
|
September 14, 2017
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer
Kerry Lynn Reynolds, Philippe L Bedard, Se-Hoon Lee, et al.
Journal for Immunotherapy of Cancer
|
January 22, 2026
Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer
Dung T Le, Gunnar Folprecht, Anna M Varghese, et al.
Cancer
|
April 23, 2014
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors
David S Hong, Ignacio Garrido-Laguna, Suhendan Ekmekcioglu, et al.
The New England Journal of Medicine
|
December 22, 2022
Sotorasib in <i>KRAS</i> p.G12C-Mutated Advanced Pancreatic Cancer
John H Strickler, Hironaga Satake, Thomas J George, et al.
Gastroenterology
|
January 20, 2024
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma
Max M Wattenberg, Sarah Colby, Ignacio Garrido-Laguna, et al.
Cell
|
May 7, 2026
Disrupted molecular glue complex drives RAS inhibitor resistance
Ben Sang, Ling Feng Ye, Zheng Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2020
Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma
Filip Janku, Haeseong Park, S Greg Call, et al.
Plos Biology
|
August 4, 2022
Kelp carbon sink potential decreases with warming due to accelerating decomposition
Karen Filbee-Dexter, Colette J Feehan, Dan A Smale, et al.
Biorxiv : the Preprint Server for Biology
|
December 25, 2025
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma
Mona Foth, Wontak Kim, Kayla T O'Toole, et al.
Cancer Research
|
May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma
Mona Foth, Wontak Kim, Kayla O'Toole, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 181) with videos related to
Sort By:
Page
of 19
BMC Cancer
|
September 14, 2017
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer
Kerry Lynn Reynolds, Philippe L Bedard, Se-Hoon Lee, et al.
Journal for Immunotherapy of Cancer
|
January 22, 2026
Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer
Dung T Le, Gunnar Folprecht, Anna M Varghese, et al.
Cancer
|
April 23, 2014
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors
David S Hong, Ignacio Garrido-Laguna, Suhendan Ekmekcioglu, et al.
The New England Journal of Medicine
|
December 22, 2022
Sotorasib in <i>KRAS</i> p.G12C-Mutated Advanced Pancreatic Cancer
John H Strickler, Hironaga Satake, Thomas J George, et al.
Gastroenterology
|
January 20, 2024
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma
Max M Wattenberg, Sarah Colby, Ignacio Garrido-Laguna, et al.
Cell
|
May 7, 2026
Disrupted molecular glue complex drives RAS inhibitor resistance
Ben Sang, Ling Feng Ye, Zheng Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2020
Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma
Filip Janku, Haeseong Park, S Greg Call, et al.
Plos Biology
|
August 4, 2022
Kelp carbon sink potential decreases with warming due to accelerating decomposition
Karen Filbee-Dexter, Colette J Feehan, Dan A Smale, et al.
Biorxiv : the Preprint Server for Biology
|
December 25, 2025
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma
Mona Foth, Wontak Kim, Kayla T O'Toole, et al.
Cancer Research
|
May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma
Mona Foth, Wontak Kim, Kayla O'Toole, et al.
Page
of 19